Absence of calcium channel alpha1C-subunit mutation in human atrial fibrillation

Jia-Lin Soon1, Liao Ping, Yeow-Leng Chua

  • 1Department of Cardiothoracic Surgery, National Heart Center, National University of Singapore, Singapore. soon.jia.lin@nhcs.com.sg

Insights

This study found no mutations in the main pore-forming subunit of the L-type voltage-gated calcium channel in patients with atrial fibrillation. This suggests that genetic mutations in this specific channel subunit do not cause atrial fibrillation.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Genetics

Background:

  • L-type voltage-gated calcium channels (CaV1.2) are crucial for cardiac function.
  • Mutations or alternative splicing in CaV1.2 have been linked to sudden cardiac death and heart failure.
  • Altered calcium channel activity is implicated in atrial fibrillation (AF).

Purpose of the Study:

  • To investigate the association between mutations in the CaV1.2 alpha(1C) subunit and atrial fibrillation.
  • To determine if genetic variations in this key channel subunit contribute to AF pathogenesis.

Main Methods:

  • Human atrial tissue was collected from 16 cardiac surgery patients.
  • DNA was extracted, amplified, and sequenced to screen for CaV1.2 alpha(1C) subunit mutations.
  • Clinical data, including arrhythmia development, were prospectively collected.

Main Results:

  • No mutations in the CaV1.2 alpha(1C) subunit were detected in any patient, irrespective of their cardiac rhythm.
  • Four patients (25%) developed new-onset postoperative paroxysmal atrial fibrillation.
  • The study did not find a correlation between AF and mutations in this specific channel subunit.

Conclusions:

  • Loss-of-function mutations in the main pore-forming subunit of the L-type voltage-gated calcium channel are not associated with atrial fibrillation in this patient cohort.
  • Other genetic or molecular mechanisms likely underlie the development of atrial fibrillation.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...